FDA Clearance Tracker · K231312
PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID
Last checked: Nov 20, 2026Latest source record: Jul 10, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jul 10, 2023
Substantially Equivalent
Time to decision
66 days
Received May 5, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K231312
- Device name
- PENTARAY® NAV ECO High Density Mapping Catheter, DECANAV® Mapping Catheter, Webster® CS Catheter with Auto ID, Webster® CS Catheter with EZ Steer Technology, Webster® CS Catheter with EZ Steer Technology with Auto ID
- Applicant
- Biosense Webster, Inc.
- Applicant location
- Irvine, CA
- Received
- May 5, 2023
- Decided
- Jul 10, 2023
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 870.1220
- Specialty
- CardiologyElectrophysiology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MTD. The earliest in FDA's data is K982540, decided Jan 27, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K231312
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Biosense Webster, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Dual Energy THERMOCOOL SMARTTOUCH SF SystemPMA supplement
P030031-S141 · Decided Jul 1, 2026 · 279 days after receipt · Panel Track
Device type: catheter, percutaneous, cardiac ablation, for treatment of atrial flutter (OAD) · Cardiology
K252972 · Decided Feb 20, 2026 · 156 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
K254085 · Decided Jan 18, 2026 · 31 days after receipt
Device type: Computer, Diagnostic, Programmable (DQK) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.